However, previous study has shown that serum level of IL-17 was elevated in type 2 diabetes mellitus patients with poor glucoregulation compared to those with good glucoregulation, and that reduction of HbA1c upon treatment was associated with a significant decrease in serum IL-17 level [39]. The gene discussed is IL17A; the disease is diabetes mellitus.